Article/Poster
2025.07.17
Academic Paper on eNK Cells in “Stem Cell Research and Therapy” Human iPSC-derived NK cells armed with CCL19, CCR2B, high-affinity CD16, IL-15, and NKG2D complex enhance anti-solid tumor activity
researchers at Healios have published a recent work revealing the anti-tumor activity of human iPSC-derived NK cells (Healios eNK cells) expressing CCL19, CCR2B, high-affinity CD16, IL-15, and NKG2D complexes by gene editing on solid tumors. This work has been published in the peer-reviewed journal “Stem Cell Research & Therapy”.